医生临床决策支持系统提示与HPV疫苗后续剂次接种:随机临床试验
该随机临床试验评估基于电子健康记录的决策支持系统(CHICA)自动提醒对医生推荐HPV疫苗第2或第3剂接种的效果。29名儿科医生共1285次临床就诊被随机分为常规实践组和提醒干预组。干预组后续接种率75.9%高于对照组64.7%,但调整分析后差异未达统计学显著性(aOR 1.52,95%CI 0.88-2.62)。
要点
- 自动提醒使后续HPV疫苗接种率从64.7%升至75.9%,但未达统计学显著。
- 调整分析后组间差异无统计学意义(aOR 1.52,95%CI 0.88-2.62)。
- 按年龄和性别分层分析同样未见显著效果。
核心结论
- 尽管干预组后续HPV疫苗接种率提高,但差异未达统计学显著性水平。
- 未来可能需要多层面干预方法研究计算机提醒的效果。
研究设计与样本
- 基于电子健康记录决策支持系统(CHICA)的随机临床试验,医生随机分为常规实践组或自动提醒组。
- 29名随机分配的儿科医生,13个月内共观察1285次临床就诊,对照组50.7%,干预组49.3%。
主要发现
- 对照组421例(64.7%)接种后续HPV疫苗,干预组481例(75.9%)接种(OR 1.72,95%CI 1.35-2.19)。
- 调整分析显示组间无差异(aOR 1.52,95%CI 0.88-2.62)。
- 按年龄11-12岁(aOR 1.66,95%CI 0.79-3.48)和13-17岁(aOR 1.19,95%CI 0.76-1.85)分析无显著差异。
- 按性别女性(aOR 1.39,95%CI 0.71-2.72)和男性(aOR 1.67,95%CI 0.95-2.92)分析无显著差异。
- 按年龄和性别分层后组间同样无统计学显著效果。
关键数值与推荐
- 患者特征:44.9%女性,59.4%黑人,22.1%西班牙裔,48.8%为11-12岁。
- 临床试验注册号NCT02558803。
临床怎么用
- 自动医生提醒可提高后续HPV疫苗接种率,但效果未达统计学显著,需结合多层面干预。
局限性
- 调整分析后差异未达统计学显著性,可能受样本量或混杂因素影响。
- 原文未明确报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: HPV vaccine is effective in preventing several cancers and anogenital warts, yet rates of HPV vaccination series completion in the United States are low. A primary reason identified by parents for vaccinating children against HPV is a health care provider's recommendation. Although most clinicians embrace vaccine recommendations, they are not always carried out evenly and subsequent HPV vaccines are missed. METHODS: Using an electronic health records-based decision support system (CHICA) clinicians were randomized to either usual practice or to receive an automated reminder to recommend the 2nd or 3rd dose of HPV vaccine. The reminder was delivered to clinicians of all intervention group eligible adolescents who had already initiated the vaccine series. Logistic regression models with generalized estimating equations were used for data analysis. RESULTS: A total of 1285 clinical encounters were observed across 29 randomized pediatric providers over a 13-month time frame (50.7% control group, 49.3% intervention group). Overall, patients were 44.9% female, 59.4% Black, 22.1% Hispanic, and 48.8% were ages 11-12 yrs. Within the control group, 421 (64.7%) received a subsequent HPV vaccine, compared to 481 (75.9%) (OR: 1.72, (95% CI 1.35-2.19)). Adjusted analysis showed no difference between the groups (aOR 1.52 (95% CI 0.88-2.62)) or when examined by age (11-12yrs aOR 1.66, (95% CI 0.79-3.48)) and 13-17yrs (aOR 1.19, (95% CI 0.76-1.85)) or gender female (aOR 1.39 (95% CI 0.71-2.72)) and males (aOR 1.67 (95% CI 0.95-2.92)). When results were stratified by both age and gender, there was similarly no statistically significant effect between the two groups. CONCLUSIONS: Automated physician reminders for subsequent 2nd and 3rd doses of HPV vaccination were used. Despite increased rates of vaccination in the intervention group, the differences did not reach the level of statistical significance. Future studies with multifaceted approaches may be needed to examine the efficacy of computer-based reminders. CLINICAL TRIAL REGISTRATION: NCT02558803, "HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3".
引用
- Wilkinson TA, Dixon BE, Xiao S, et al. Physician clinical decision support system prompts and administration of subsequent doses of HPV vaccine: A randomized clinical trial. Vaccine. 2019. PMID: 31201057. doi:10.1016/j.vaccine.2019.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。